WO2005085317A1 - Ultraviolet-curing composition - Google Patents
Ultraviolet-curing composition Download PDFInfo
- Publication number
- WO2005085317A1 WO2005085317A1 PCT/JP2005/003351 JP2005003351W WO2005085317A1 WO 2005085317 A1 WO2005085317 A1 WO 2005085317A1 JP 2005003351 W JP2005003351 W JP 2005003351W WO 2005085317 A1 WO2005085317 A1 WO 2005085317A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- integer
- group
- compound
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
Definitions
- the present invention relates to a cation-curable ultraviolet-curable composition suitable as a display such as a liquid crystal display, a plasma display, and a touch panel, and an optical material such as an optical lens that requires transparency.
- the present invention relates to a novel biphenyl derivative having an oxetane ring capable of cationic polymerization and a method for producing the same.
- An ultraviolet curable composition is widely used as an optical material because of its features such as excellent productivity and easy application of a cured product having a fine shape.
- a UV curable composition is poured into a mold having fine irregularities, covered with a transparent plastic substrate, cured by irradiating UV rays, and cured.
- the ultraviolet-curable composition is also used as a binder for a diffusion sheet or a material for bonding various films.
- UV curable compositions Most of the raw materials of the ultraviolet curable composition are acrylic compounds, and acrylic compounds occupy most of the optical applications as described above.
- various types of optical members and methods for producing the same have been devised using ultraviolet-curable compositions, and accordingly, strict performance is required for ultraviolet-curable compositions.
- UV curable compositions On the other hand, there are demands for a conventional acrylic compound having good adhesion to a substrate which is difficult to adhere to, a material having a low shrinkage upon curing, and a material having a low water absorption.
- the cationically curable composition using the epoxy conjugate compound and the oxetane conjugate compound has better and better performance in terms of these physical properties than the acrylic compound.
- Oxetane conjugates are compounds that have attracted attention in recent years as monomers that can be cured by cationic polymerization or the like, and many oxetane conjugates have been reported.
- a bisoxetane ether conjugate obtained by contacting a 3-alkyl 3-hydroxymethyloxetane with an ⁇ , ⁇ -dibumoalkane in the presence of an aqueous alkali metal hydroxide solution and a phase transfer catalyst has been reported.
- Non-Patent Document 1 Non-Patent Document 1
- R—R represents a hydrogen atom or a methyl group
- R and R represent a hydrogen atom or
- the cationically curable composition includes a cationically polymerizable conjugate, which is an epoxy conjugate or a Z or oxetane conjugate, a glycidyl group or a 3-ethyl-3,3-xentanylmethyl group having an ether bond.
- a cationically polymerizable conjugate which is an epoxy conjugate or a Z or oxetane conjugate, a glycidyl group or a 3-ethyl-3,3-xentanylmethyl group having an ether bond.
- An aromatic etherified compound such as phenylene and naphthalene, and a photo-thione curable composition containing a photo-thione initiator have been reported (for example, see Patent Document 9). .
- a transmission type characterized by containing a bisphenol type epoxy (meth) acrylate and / or urethane (meth) acrylate, a vinyl ether conjugate, a photodynamic thione polymerization initiator and a photoradical polymerization initiator.
- An ultraviolet curable composition for a screen has been reported (for example, see Patent Document 10).
- a polymerizable conjugate in which 5-95% of epoxy groups in the epoxy compound are (meth) acryloyl and 5-60% of hydroxyl groups in Z or phenoxy resin are a, ⁇ -unsaturated monoisocyanate.
- Patent Document 1 JP-A-6-16804
- Patent Document 2 German Patent No. 1021858
- Patent Document 3 JP-A-7-53711
- Patent Document 4 JP-A-7-173279
- Patent Document 5 JP-A-8-245783
- Patent Document 6 JP-A-9-309950
- Patent Document 7 JP-A-10-212343
- Patent Document 8 JP 2001-31665 A
- Patent Document 9 JP-A-2003-096184
- Patent Document 10 JP-A-07-199359
- Patent Document 11 JP 2001-163939 A
- Non-patent Document l Bull.Chem.Soc.Jpn., 61, pp. 1653 (1989)
- Non-Patent Document 2 Pure Appl.Chem., A29 (10), pp. 915 (1992)
- Non-Patent Document 3 Pure Appl.Chem., A30 (2 & 3), pp. 189 (1993)
- the problem to be solved by the present invention is to provide a resin having a small yellowing that can be used for optical applications where colorless and transparent properties are strictly required. And a method for producing the same.
- an ultraviolet-curable composition comprising at least one compound represented by the following formula (1), a compound A having two or more cationically polymerizable groups, and a photoactive thione polymerization initiator;
- R 1 represents a hydrogen atom or a methyl group
- n represents an integer of 0 to 20
- B represents an alkyl group having 1 to 16 carbon atoms, and an alkoxy group having 1 to 16 carbon atoms.
- the number L of substituents of B represents an integer from 0 to 5
- the number m of substituents of B represents an integer from 0 to 4
- Z represents the following formula (2) or the following formula: (Represents (3).)
- R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.
- R 3 represents a hydrogen atom or a methyl group.
- R 1 represents a hydrogen atom or a methyl group
- R 2 represents a hydrogen atom or an alkyl group having 1 to 16 carbon atoms
- n represents an integer of 0 to 20
- B represents a carbon number. It represents an alkyl group of 1 to 6, an alkoxy group of 1 to 6 carbon atoms, or a halogen atom
- the number of substituents of B represents an integer of 0 to 5
- the number of substituents of B is an integer of 0 to 4.
- a force-thione curable composition containing a compound represented by the formula (4) according to (8) and a cationic polymerization initiator
- a method for producing a compound represented by the formula (7) which comprises reacting a compound represented by the formula (5) with a compound represented by the formula (6) in the presence of an alkali. is there.
- R 1 represents a hydrogen atom or a methyl group
- n represents an integer of 0 to 20
- B represents an alkyl group having 16 carbon atoms
- B represents an alkyl group having 11 carbon atoms.
- 6 represents an alkoxy group or a halogen atom
- the number of substituents L of B represents an integer from 0 to 5
- the number of substituents m of B represents an integer from 0 to 4.
- R 1 represents a hydrogen atom or a methyl group
- R 2 represents a hydrogen atom or a carbon atom
- N represents an alkyl group of 1 to 6
- n represents an integer of 0 to 20
- B represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom
- L represents an integer from 0 to 5
- B represents an integer from 0 to 4.
- the cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays and touch panels, and optical lenses. It can be suitably used as a required optical material.
- the compound represented by the formula (4) can be suitably used as a raw material of a cured product requiring transparency.
- FIG. 1 Slide glass and polyethylene terephthalate used in Examples and Comparative Examples
- FIG. 3 shows an ultraviolet-visible absorption spectrum of a (PET) film.
- FIG. 2 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 1).
- FIG. 3 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 2).
- FIG. 4 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 2).
- the horizontal axis of FIG. 14 is wavelength (nm), and the vertical axis of FIG. 14 is transmittance (%).
- Thick and solid line in FIG. 2 transmittance of the composition of Example 3 sandwiched between glass slides and cured.
- Thick solid line in Fig. 3 transmittance of the composition of Example 3 cured on PMMA Thin solid line in Fig. 3: Transmittance of the composition of Comparative Example 2 cured on PMMA Fig. 3 Dashed line: Transmittance of the composition of Comparative Example 3 cured on PMMA Thick solid line in Fig. 4 Transmittance of the composition obtained by curing the composition of Example 3 on PMMA Thin and solid line in FIG. 4: Transmittance of the composition obtained by curing the composition of Comparative Example 4 on PMMA Dashed line in FIG. 4: Composition of Comparative Example 5 Of PMMA cured on PMMA Best mode for carrying out the invention
- the ultraviolet-curable composition of the present invention comprises at least one compound represented by the following formula (1),
- the ultraviolet-curable composition of the present invention forms a cationically polymerizable resin.
- R 1 represents a hydrogen atom or a methyl group
- n represents an integer of 0 to 20
- B represents an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, Or, represents a halogen atom
- the number L of substituents of B represents an integer from 0 to 5
- the number m of substituents of B represents an integer from 0 to 4
- Z represents the following formula (2) or the following formula ( Represents 3).
- R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.
- R 3 represents a hydrogen atom or a methyl group.
- the compound of the present invention is represented by the following formula (4), and the compound represented by the formula (4) can be suitably used for cation polymerization.
- R 1 represents a hydrogen atom or a methyl group
- R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms
- n represents an integer of 0-20.
- B represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom
- the number of substituents L of B represents an integer from 0 to 5
- the number m of substituents m of B is Represents an integer from 0 to 4.
- the compound represented by the formula (4) is a compound represented by the formula (1), wherein Z of the compound is the formula (2). Therefore, description of the compound represented by the formula (4) is omitted.
- N in the formula (1) represents an integer of 0 to 20, preferably 0 to 5, and particularly preferably 0.
- n 20 or less, the effect of reducing the yellowing of the cured product with a high concentration of the biphenyl skeleton is high, which is preferable.
- B represents a monovalent substituent at any position on the aromatic ring
- the number of substituents L represents an integer from 0 to 5
- the number of substituents m of B represents an integer from 0 to 4.
- B preferably represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom, and is not limited to other groups as long as the cationic polymerization of the compound represented by the formula (1) is not inhibited. Any monovalent substituent can be selected.
- the alkyl group and the alkoxy group may have a branch.
- examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
- a methyl group, a methoxy group, a methyl group which is preferably a fluorine atom or a bromine atom is particularly preferable.
- L B and m B can be independently selected from the same or different substituents.
- L and m in the formula (1) are preferably 0 or 2.
- L and m in the formula (1) are 2, those bonded to the 3, 5, 3, 5, and 5 positions are preferred.
- Z of the compound represented by the formula (1) is preferably a force Z represented by the formula (2) or (3), and preferably has an oxetane ring represented by the formula (2).
- the bonding position of the compound having an oxetal group or an epoxy group in the above formula (1) of the present invention is at the 2-, 3- or 4-position, preferably at the 2- or 4-position.
- the compound represented by the formula (1) is obtained by converting the compound represented by the formula (5) and the oxetane compound represented by the formula (6) or the epoxy conjugate represented by the formula (8) to an alkali. It can be obtained by reacting in the presence. A solvent may be used if necessary in this reaction. Further, a phase transfer catalyst may be used. [0048]
- R 1 represents a hydrogen atom or a methyl group
- n represents an integer of 0 to 20
- B represents an alkyl group having 1 to 6 carbon atoms
- B represents an alkyl group having 1 to 16 carbon atoms.
- the number of substituents L of B represents an integer from 0 to 5
- the number of substituents m of B represents an integer from 0 to 4.
- R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.
- R 3 represents a hydrogen atom or a methyl group.
- those other than ⁇ -force O are 2-phenylphenol, 3-phenylphenol or 4-phenylphenol, and their nucleus-substituted products are ethylene oxide or propylene oxide.
- Compound represented by the formula (5) The number of n in the compound represented by the formula (1) is controlled by controlling the amount of ethylene oxide or propylene oxide to be added. can do.
- the substituent B can be introduced into the nucleus of the raw material phenol by a known method, for example, a methyl group can be introduced by a Friedel-Crafts reaction.
- n is an integer, but when it is a mixture of different numbers of n, n may be represented by a number having a decimal point. is there . In this case, n represents the average value of a mixture of compounds represented by the formula (1) having different numbers of n.
- Examples of the oxetane compound represented by the formula (6) used in the present invention include 3-alkyl 3-chloromethyloxetane and 3-chloromethyloxetane.
- Examples of the 3-alkyl 3-chloromethyloxetane include 3-chloromethyl-3-methyloxetane, 3-chloromethyl-3-ethyloxetane, and 3-chloromethyl-3-propyloxetane.
- 3-alkyl-3-chloromethyloxetane is preferred, and 3-chloromethyl-3-methyloxetane or 3-chloromethyl-3-ethyloxetane is more preferred.
- the compound represented by the formula (5) and the compound represented by the formula (6) or (8) are also used when synthesizing the compound represented by the formula (1).
- the alkali include an alkali metal, an alkali metal hydroxide, an alkali metal carbonate, an alkaline earth metal hydroxide, an alkaline earth metal carbonate, and an alkali metal hydride.
- Metal, alkali metal hydroxide or alkali metal hydride A plurality of these alkalis may be used in combination.
- Specific examples of alkalis used in this synthesis include sodium hydroxide, potassium hydroxide, lithium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium hydride, potassium hydride, and sodium metal. , And metallic potassium.
- sodium hydroxide and potassium hydroxide are preferred also because of the reason that a sufficient transfer ratio can be obtained in a short time.
- the amount of the alkali to be used is preferably 1 mol or more, more preferably 18 mol, particularly preferably 1 mol, to 1 mol of the compound represented by the formula (5). It is. In consideration of the post-treatment, one mole of the alkali is added to one mole of the compound represented by the formula (5). Can be used. When used as an aqueous solution or suspension of an alkali, the alkali concentration is preferably from 1 to 96% by weight, more preferably from 20 to 96% by weight.
- alkali metal hydroxide preferably, a 5-60% by weight aqueous solution or a powdered sodium hydroxide or potassium hydroxide is used, and more preferably, a 40-50% by weight aqueous solution. Is used.
- a solvent inert to the raw materials and the reaction products can be used.
- This solvent is preferably a solvent that azeotropes with water generated in the system during synthesis.
- the solvent include benzene, toluene, xylene, ethylbenzene, methylcyclohexane, ethylcyclohexane, n-butynoleatel and the like.
- the reaction time can be reduced by distilling the water generated in the synthesis system together with the solvent.
- the amount of the solvent is preferably 0.05 to 100 parts by weight, more preferably 0.1 to 20 parts by weight, based on 1 part by weight of the total of the raw material and the reaction product in the reactor.
- the amount of the solvent is within the above range, the yield per unit volume is high, the energy for recovering the solvent is small, and it is economical.
- toluene, xylene, methylcyclohexane, ethylcyclohexane and the like are suitably used.
- phase transfer catalyst that can be used in the synthesis of the compound represented by the formula (1)
- known phase transfer catalysts for example, WP Weber, GW Gokel, Iwao Tabushi, Takako Nishitani, “ ! (Shift catalyst) and those described in “Chemical Doujin Co., Ltd.
- organic quaternary ammonium salts and phosphonium salts are preferred because of their high catalytic ability.
- Specific examples include tetra-n-butylammonium-bromobromide, benzyltriethylammonium-bromobromide, trioctylmethylammo-bromochloride, tetra-n-butylphospho-bromochloride, trioctylethylphospho-pambromide and tetraphenylphospho-bromochloride. And the like.
- the reaction temperature at the time of synthesizing the compound represented by the formula (1) is preferably from 80 to 150 ° C, particularly preferably from 100 to 120 ° C.
- the reaction time for synthesizing the compound represented by the formula (1) depends on the reaction temperature and whether or not a phase transfer catalyst is used, but is preferably 4 to 50 hours.
- the reaction solution cooled to room temperature is washed with water, distilled, and the like, whereby the target compound (target substance) represented by the formula (1) can be obtained.
- the desired product can be confirmed by J HN MR and 13 C-NMR spectrum.
- Z is preferably represented by the formula (2) or from the curability of the power composition represented by the formula (2) or (3) or A compound represented by the formula (3), which is an R 3 methyl group, is more preferably a compound represented by the formula (2).
- R 2 in the formula (2) represents a hydrogen atom or an alkyl group having 116 carbon atoms, and the alkyl group may have a branch.
- R 2 is preferably a methyl group or an ethyl group.
- composition of the present invention contains at least one compound represented by formula (1), and the kind of R ⁇ R 2, R 3 and substituents B, L, m, n number of It is possible to use a mixture of a plurality of compounds having different formulas, and it is also possible to use a mixture of compounds having different Z in the formula (1).
- the bonding position is at the 2-position, the compound is liquid at room temperature, so that the composition is liquid even if the number of components is increased. Therefore, it is preferable that the compound having an oxetanyl group or an epoxy group be bonded at the 2-position.
- the binding site of the compound having an oxetanyl group or an epoxy group is preferably at the 2-position.
- the total compounding amount of the compound represented by the formula (1) is not particularly limited, but is preferably from 10 to 99, based on 100 parts by weight of the cationically polymerizable component. Parts by weight, more preferably 20 to 90 parts by weight, particularly preferably 30 to 80 parts by weight. When the blending number is within the above range, the effect of reducing yellowing of the cured product is high!
- the cationically polymerizable components include a compound represented by the formula (1), a compound A having two or more cationically polymerizable groups, and a compound B having one cationically polymerizable group.
- the cationic polymerizable group include an epoxy group, an oxetane group, and a vinyl ether group.
- the compound represented by the formula (1) can be used for applications where the transparency of the cured product is not required. I'm sorry.
- the cationic polymerization initiator in the present invention acts so as to generate an acid component by being activated by adaptation of light or heat to induce cationic polymerization of the cationically polymerizable group in the composition. is there.
- the cationic polymerization initiator it is preferable to use any light-powered thione polymerization initiator that is activated by irradiation with light and can induce polymerization of the cationically polymerizable group. Further, a photosensitizer can be used in combination. Further, as the cationic polymerization initiator, any thermal cationic polymerization initiator can be used as long as it is activated by heating and can induce polymerization of the cationically polymerizable group.
- the photo-thione polymerization initiator in the present invention is a compound that generates an acid capable of undergoing cationic polymerization by irradiation with ultraviolet light.
- Examples of the photoinitiated thione polymerization initiator include oxalate salts and organometallic complexes.
- organometallic complexes examples include an iron-allene complex, a titanocene complex, and an arylsilanol aluminum complex.
- o-pium salts include diazo-pium salt, odonium salt, sulfo-pum salt, selenium salt, pyridi-p-m salt, ferrose-pum salt, phospho-pum salt, and Dipium salt and the like.
- sulfode such as an aromatic sulfo-dum salt, dialkylphenacyl sulfo-dum salt or the like is preferred in terms of curability and less yellowing.
- -Pham salts are preferred, aromatic sulfo-pam salts are more preferred, and triaryl sulfo-pam salts are particularly preferred.
- the anion is BF-AsF-
- triarylsulfo-pium salts include Cyracure UVI-6990, UVI-6992, and UVI-6974 manufactured by Dow Chemical Japan, and Asahi Denka Kogyo Co., Ltd. Adeki Optomatic SP-150, SP-152, SP-170, SP-172, etc., WP AG-593, WPAG-596, WPAG-640, WP AG-641, etc. manufactured by Wako Pure Chemical Industries, Ltd. And can be used in the present invention.
- aromatic rhododium salts include UV-9380C manufactured by GE Toshiba Silicone, PHOTOINITIATOR2074 manufactured by Rhodia, WPI-116, WPI-113 and CD-1012 manufactured by Wako Pure Chemical Industries, Ltd. (trade names) And Sartoma Co., Ltd.).
- UVI-6990 and UVI-6992 are particularly preferred in terms of curability and low yellowing.
- the blending amount of the photo-induced thione polymerization initiator in the present invention can be appropriately adjusted according to the type and irradiation amount of ultraviolet rays.
- the amount of the photoinitiated thione polymerization initiator be within the above range, since sufficient curability can be obtained, and heat resistance after polymerization and low water absorption are also sufficient.
- a sensitizer may be used in combination with the composition of the present invention in order to increase the activity of the photoinitiated thione polymerization initiator.
- the sensitizer that can be used in the present invention it is possible to use a compound disclosed by Krivero in Advanced in Polymer Science (Adv. In Plymer Sci., 62, 1 (1984)). Specific examples include pyrene, perylene, atalidine orange, thioxanthone, 2-cloth thioxanthone, and benzoflavin.
- a compound widely used as a photo-radical polymerization initiator can also be used.
- the radical polymerization initiator is used.
- the radical polymerization initiator include compounds that generate a radical by heat, light, a redox reaction, or the like. Examples of such a substance include an organic peroxide, an azoi compound, a redox initiator, and the like.
- benzoxanone such as benzophenone, 2,4 getylthioxanthone, 2 isopropylthioxanthone, 2,4 dichloromouth thioxanthone
- benzoin ether such as benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether
- Benzyldimethyl ketals such as 2,2-dimethoxy-1,2-diphenyl-1-one, 2-hydroxy-2-methyl-1-phenylpropane-1 on, 1- (4-isopropylpropyl) -2-hydroxy-2- To methyl propane 1 on, 1-hydroxycyclo ⁇ -Hydroxyalkylphenones such as xylphenol ketone; ⁇ -dicarboxylic conjugates such as camphorquinone; and the like.
- a sulfo-dimethyl salt is used as a photothione polymerization initiator and no sensitizer is used. Is preferred.
- the wavelength range of ultraviolet light used for curing the composition is not particularly limited, but is preferably 200 to 380 nm in consideration of both curability and low yellowing. When importance is placed solely on the small amount of yellowing, it is preferably from 300 to 380 nm, particularly preferably from 320 to 380 nm.
- the light source that can be used in the case of performing polymerization using an active energy ray is not particularly limited, but has a light emission distribution at a wavelength of 400 nm or less, such as a low-pressure mercury lamp, a medium-pressure mercury lamp, and a high-pressure mercury lamp.
- a low-pressure mercury lamp such as a low-pressure mercury lamp, a medium-pressure mercury lamp, and a high-pressure mercury lamp.
- Mercury lamps, ultra-high pressure mercury lamps, chemical lamps, black light lamps, microwave-excited mercury lamps, metal halide lamps, and the like can be used.
- the light irradiation intensity of the composition is controlled for each target product and is not particularly limited.However, the light wavelength range effective for activating the cationic photoinitiator having photolatitude is used.
- the light irradiation intensity (depending on the polymerization initiator) is 0.1-100 mW / cm 2 . It is preferable that the light irradiation intensity of the composition be within the above range, since the reaction time is appropriate. Further, it is preferable because the heat irradiated by the lamp power and the heat generated during the polymerization of the composition do not cause a decrease in cohesive strength, yellowing or deterioration of the support of the obtained cured product.
- the light irradiation time for the composition is controlled for each target product and is not particularly limited, and is expressed as a product of the light irradiation intensity and the light irradiation time in the light wavelength region.
- the integrated light amount is set to be 10-5, OOOmi / cm 2 .
- the integrated light amount of the composition is within the above range, the generation of the active species from the initiator is sufficient, and the characteristics of the obtained cured product are not deteriorated. Further, the irradiation time is short, which is preferable since productivity is improved.
- most of the compositions are dried to the touch by cationic polymerization 0.1 to several minutes after the irradiation with the active energy ray, but it is sometimes preferable to use heating in combination to promote the cationic polymerization reaction. Better.
- the compound A having two or more cationically polymerizable groups to be blended in the composition of the present invention preferably has 10 or less, more preferably 5 or less, thiothionizable groups.
- Examples of the compound A having two or more cationically polymerizable groups include a compound A having an epoxy group, a compound A having an oxetanol group, and a compound A having a vinyl ether group. Mixtures can be used.
- a bifunctional glycidyl ether-type epoxy compound is preferred when adhesion is important, and a difunctional or higher functional epoxy compound is preferred when curability is preferred.
- Preferred are cyclic epoxy conjugates and Z or oxetane compounds. When the elastic modulus at or above the glass transition temperature is to be improved, trifunctional or higher is preferred.
- the compound A is preferably contained in an amount of 1 to 80 parts by weight, more preferably 5 to 60 parts by weight, based on 100 parts by weight of the compound component containing a cationically polymerizable group of the composition of the present invention. More preferably, it is contained in an amount of 10 to 50 parts by weight.
- Examples of the compound A having an epoxy group include dicyclopentagendioxide, limonene dioxide, 4-butylcyclohexenedioxide, 3,4 epoxycyclohexylmethylenoleate 3,4-epoxycyclohexanyl ureboxylate, (3,4-epoxycyclohexyl) adipate, bisphenol A epoxy resin (bisphenol A diglycidyl ether), halogenated bisphenol A epoxy resin, hydrogenated bisphenol A epoxy resin , Bisphenol S diglycidyl ether, halogenated bisphenol S diglycidyl ether, hydrogenated phenol bisphenol S diglycidyl ether, bisphenol F type epoxy resin, halogenated bisphenol F type epoxy resin, hydrogenated bisphenol F-type epoxy resin, 1, 6 Hexanediol diglycidyl ether, polytetramethylenglycol diglycidyl ether, compounds in which both ends of polybutadiene are glycidyl etherified,
- Epoxy novolak resin trimethylolpropane triglycidyl ether, pentaerythritol tetraglycidyl ether, 3,4-epoxycyclohexylmethyl-3 ', 4' epoxycyclohexanecarboxylate, 2- (3,4-epoxycyclo) Xinole 5,5-spiro 3,4-epoxy) cyclohexane metadioxane, bis (3,4-epoxycyclohexylmethyl) adipate, bis (3,4-epoxy 6— Methylcyclohexylmethyl) adipate, 3,4 epoxy 6-methylcyclohexyl 3 ', 4' epoxy 6'-methylcyclohexanecarboxylate, methylenebis (3,4 epoxycyclohexane), dicyclopentadiene epoxide, ethylene Glycol di (3,4-epoxycyclohexylmethyl) ether, ethylenebis
- JP-A-8-85775 and JP-A-8-134405 various kinds of oxetane conjugates described in JP-A-8-85775 and JP-A-8-134405 are exemplified, and among them, a compound having two or more oxetal groups can be used. it can.
- Examples of the compound A having a butyl ether group include cyclohexane dimethanol dibutyl ether, triethylene glycol divinyl ether, and novolak type divinyl ether.
- Examples of the compound B to be added to the composition of the present invention include a compound B having an epoxy group, a compound B having an oxetal group, and a compound B having a vinyl ether group. It can also be used.
- Compound B is preferably contained in an amount of 5 to 60 parts by weight, more preferably 10 to 50 parts by weight, based on 100 parts by weight of the compound component containing a cationically polymerizable group of the composition of the present invention. Is more preferable! / ,.
- Examples of the compound B having an epoxy group include ⁇ -methyl phenylepoxide, phenylglycidyl ether, and 2-ethylhexyl, such as butylcyclohexene oxide, 4-butylepoxycyclohexane, and 1,2-epoxyhexadecane.
- Glycidyl ether dodecyl glycidyl ether, glycidyl methacrylate, dioctyl epoxyhexahydrophthalate, di-2-ethylhexyl epoxyhexahydrophthalate, monoglycidyl ethers of higher aliphatic alcohols; phenol, cresol, butylphenol Or monoglycidyl ethers of polyether alcohols obtained by adding alkylene oxide thereto; monoglycidyl esters of higher fatty acids;
- Examples of the compound having a butyl ether group include hydroxyethyl butyl ether, hydroxybutynolebininoleatene, dodecinolebininoleatene, propeninoleatenolepropylene carbonate and cyclohexylvinyl And the like.
- compounds having an oxetanyl group are excellent in curability, and thus can be preferably added to the composition of the present invention.
- a monofunctional compound having an oxetanyl group that is, a compound having one oxetal group in one molecule
- the cured product of the present invention can be applied to a substrate having difficult adhesion.
- a particularly preferable example is 3-ethyl-3- (phenoxymethyl) oxetane (aronoxetane II- 211 (II)).
- a compound having at least one radically polymerizable group in the molecule may be blended as a polysynthetic component.
- acrylates (meth) acrylic acid, (meth) acrylamide, N-methylol (meth) acrylamide, N-methoxymethyl (meth) acrylamide and N-methoxybutyl (meth) acrylamide.
- the (meth) atalyloyl group means an atalyloyl group and a methacryloyl group.
- compounds having one (meth) atalyloyl group include, for example, N-butylpyrrolidone, tetrahydrofurfuryl (meth) atalylate, and 2-ethylhexyl acrylate Hydroxyalkyl (meth) acrylates, such as 2-hydroxyethyl (meth) acrylate and 2-hydroxypropyl (meth) acrylate, and alkylene oxides of phenol, such as phenol and ethylene oxide (Meta) acrylates of adducts, (meta) acrylates of alkyl phenols such as noyulphenol, alkylene oxides such as ketene, etc.
- the above-mentioned alkyl is a lower alkyl group which may have a branch, and specifically, has 16 to 16 carbon atoms such as ethyl and propyl.
- the above-mentioned alkylene is a lower alkyl group which may have a branch, and specifically, an alkylene having a carbon number of 116 such as ethylene and propylene.
- the above-mentioned alkylene oxides are those composed of good lower alkylenes such as ethylene and propylene. In the cationically curable composition of the present invention, two or more of these compounds are used in combination.
- a compound having two or more atariloyl groups in one molecule includes a diatalylate of ethylene oxide-modified bisphenol F (for example, "Aronix M208 manufactured by Toagosei Co., Ltd.) )), Diatalylate of ethylene oxide-modified bisphenol A (for example, “Aronix M210" manufactured by Toagosei Co., Ltd.), and diatalylate of propylene oxide-modified bisphenol A (for example, "Light Atarilate BP” manufactured by Kyoeisha-Danigaku Co., Ltd.) — 4PA ”), ethylene oxide-modified isocyanuric acid diatalylate (eg, Seiko Co., Ltd.
- ethylene oxide-modified isocyanuric acid diatalylate eg, Seiko Co., Ltd.
- Alonics M215 polypropylene glycol diatalylate
- Polypropylene glycol diatalylate eg, Toagosei Co., Ltd.
- Alonics M225 polyethylene glycol diatalylate
- Polyethylene glycol diatalylate eg, Toagosei Co., Ltd.
- “Aronics M240”) Polytetramethylene glycol diatalylate (for example, “Kyoeisha-Danigaku Co., Ltd.“ Light Atarilate PTMGA-250 ”), pentaerythritol di-atalylate monostearate (eg, Toagosei Co., Ltd.“ Aronix M233 ”), Neopentyldaricole diatalylate, hexanediol diatalylate, nonanediol diatalylate, dimethylol tricyclodecane diatalylate (for example, “Kyoeisha Chemical Co., Ltd.“ Light Atalylate DCP-A ”), trimethylolpropane Acrylic acid benzoate (for example, Kyoeisha Co., Ltd.
- Light Atarilate BA-134" hydroxypivalic acid neopentyl cholesteric alcohol diatalylate (for example, Kyoeisha I-Danigaku Co., Ltd. "Light Atarilate HPP-A"), pentaerythritol triatalylate ( For example, “Aronix M305” manufactured by Toagosei Co., Ltd., trimethylolpropane triatalylate (eg, “Aronix M309” manufactured by Toagosei Co., Ltd.), and alkylene oxide-modified trimethylolpropanetriatalylate (eg, manufactured by Toagosei Co., Ltd.) "Alonics M310", “Alonics M350”), ethylene oxide-modified isocyanuric acid triatalylate (eg, Toagosei Co., Ltd.
- composition of the present invention may optionally contain a filler such as silica, alumina, and other metal oxides. Thereby, thixotropy can be imparted.
- a material having ion exchangeability When used as an electrical insulating material or when a corrosive substrate is used, it is preferable to add a material having ion exchangeability, more preferably an inorganic material, and particularly preferably a negative electrode. It has ion exchange ability.
- suitable inorganic anion exchangers include IXE-500, IXE-530, IXE-550, IXE-700, and IXE-800 (V, the deviation is also manufactured by Toagosei).
- a coupling agent such as a silane coupling agent can be added to the composition of the present invention for the purpose of improving the adhesion of the cured product to an inorganic material.
- Suitable silane coupling agents include ⁇ - (3,4 epoxycyclohexyl) ethyltrimethoxysilane (Shin-Etsu Chemical Co., Ltd., ⁇ -303), and ⁇ -glycidoxypropyltrimethoxysilane (Shin-Etsu Rigaku Co., Ltd.) , ⁇ -403), ⁇ -glycidoxypropyltriethoxysilane (Shin-Etsu Chemical Co., Ltd., ⁇ -403), ⁇ -glycidoxypropylmethyljetoxysilane (Shin-Etsu Iridaku, ⁇ -402), 3-ethylethyl 3 -— [[3- (triethoxysilyl) propoxy] methyl ⁇ oxetane
- An antioxidant can be added to the composition of the present invention for the purpose of improving heat resistance and the like.
- examples of the antioxidant to be contained in the composition of the present invention include a phenolic antioxidant, a zeolite antioxidant, a phosphorus antioxidant, and an amine antioxidant, and particularly preferred are It is a phenol-based antioxidant.
- phenolic antioxidants examples include hydroquinone monomethyl ether, 2,6-di-t-butylhydroxytoluene (for example, BHT manufactured by Kawaguchi Chemical), 2,2-methylenebis (4-methyl-6-t-butylphenol), 4, 4'butylidenebis- (3-methyl-6-t-butylphenol), triethylene glycol bis- [3- (3,1-tert-butyl-4-hydroxy-5-methylphenol)] propionate, pentaerythritol-tetrakis [3 — (3,5-di-tert-butyl-4 —hydroxyphenyl) propionate] (Tinoku's Irgano manufactured by Specialty Chemicals) x 1010), n-octadecyl-3-([3,5, di-tert-butyl-4, -hydroxyphenyl) propionate], 4,4, -thiobis (3-methyl-6-tert-butyl) phenol, etc.
- a powdery reinforcing agent or filler such as metal oxides such as aluminum oxide and magnesium oxide may be used, if necessary.
- metal carbonates such as calcium carbonate and magnesium carbonate, diatomaceous earth powder, basic magnesium silicate, calcined clay, fine powdered silica, fused silica, crystalline silica and other metal compounds, and metal water such as aluminum hydroxide Oxides, other materials, such as kaolin, myriki, quartz powder, graphite, molybdenum disulfide, and other fibrous reinforcing agents and fillers such as glass fiber, ceramic fiber, carbon fiber, alumina fiber, and silicon carbide fiber , Boron fiber, polyester fiber, polyamide fiber and the like. These can be added in an amount of 10 to 900 parts by weight based on 100 parts by weight of the composition of the present invention.
- a coloring agent for example, titanium dioxide, iron black, molybdenum red, dark blue, ultramarine, cadmium yellow, cadmium red, antimony trioxide, red phosphorus, and a bromide compound And triphenyl phosphate and the like.
- a coloring agent for example, titanium dioxide, iron black, molybdenum red, dark blue, ultramarine, cadmium yellow, cadmium red, antimony trioxide, red phosphorus, and a bromide compound And triphenyl phosphate and the like.
- various curable monomers, oligomers and synthetic resins can be added to the composition of the present invention for the purpose of improving the properties of the resin in the molded article and the like.
- diluents for epoxy resin such as monoepoxy, phenol resin, alkyd resin, melamine resin, fluorine resin, chlorinated vinyl resin, acrylic resin, silicone resin, polyester resin, etc. Two or more combinations can be given.
- the mixing ratio of these resins is within a range that does not impair the cationic polymerizability, which is the original property of the composition of the present invention, that is, 50 parts by weight or less for 100 parts by weight of the composition of the present invention. Is preferred.
- composition of the present invention examples include heat-melt mixing, melt-kneading using a roll or a kneader, wet mixing using an appropriate organic solvent, and dry mixing.
- the composition of the present invention is cured by heat when a thermal cationic polymerization initiator is used, or by an active energy ray when an active energy linear cationic polymerization initiator is used.
- the thermal cationic polymerization initiator is usually carried out at a temperature not lower than the temperature at which the generation of cationic species or Lewis acid is started, usually at 50 to 200 ° C.
- heat can be applied by a generally known method, and the conditions and the like are not particularly limited.
- composition containing the formula (1) of the present invention can be cured by irradiation with a small amount of active energy rays (ultraviolet rays or the like) since oxygen inhibition during polymerization is small. The same applies to polymerization by heat.
- active energy rays ultraviolet rays or the like
- Examples of the method of using the composition of the present invention in which the formula (1) is blended include a method of applying the composition to a substrate and then irradiating the composition with ultraviolet light.
- Examples of the substrate include molded resin products (plastics) such as polycarbonate and polymethylmethacrylate, metals, glass, concrete, wood such as natural wood and synthetic wood, stone materials, and paper.
- the cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays and touch panels, and optical lenses. It can be suitably used as a required optical material. That is, the cured product of the composition of the present invention can be suitably used for an optical material. Examples of use of the composition of the present invention are illustrated below. For example, it can be used for a lens sheet light guide plate of a liquid crystal display and its surface. It is also used as a diffusion sheet when used as a binder for liquid crystal displays, etc., as a hard coat on the surface of various films such as deflection films for liquid crystal displays, etc. It can be used as a liquid crystal sealant.
- a material for covering the wiring of the plasma display touch panel as a material for bonding the edge of the display screen, as a dot spacer for the touch panel, as a DVD substrate, as a DVD substrate, Used as an adhesive for DVDs, as a coating layer for DVDs, as a core / clad for optical waveguides, as a lens for various optical devices, as a sealing part for blue LEDs, and as a sealing part for white LEDs can do.
- the cured product of the composition of the present invention has a high refractive index, and is excellent in curability, heat resistance, flame retardancy, and mechanical properties. Therefore, it can be used for paints and coating materials, adhesives and the like. [0102] ⁇ Example>
- reaction solution was stirred for 14 hours while maintaining the temperature at about 110 ° C. Thereafter, 0.3 mol of 3-chloromethyl-3-ethyloxetane and 0.02 mol of tetrabutylammonium-bromobromide were added to the reaction solution, and the reaction solution was stirred for further 3 hours while maintaining the reaction solution at about 110 ° C.
- reaction solution was cooled to room temperature, 250 g of water and 250 g of toluene were dried and extracted, and separated into an organic layer and an aqueous layer. The obtained organic layer was washed three times with 250 g of water. The solvent was distilled off from the obtained organic layer under reduced pressure to obtain 255 g of a crude product.
- the crude product was purified by distillation under reduced pressure (192 ° C-196 ° C, 400 Pa), and 4 [(3-ethyloxetane-3-yl) methoxy] biphenyl (formula (10) below) was converted to a white solid. 223. lg (yield: 83%, purity: 99%) was obtained.
- Table 1 After mixing the components and their proportions shown in Table 1 according to a conventional method to prepare a cationically curable ultraviolet-curable composition, various physical properties were evaluated.
- the abbreviations in Table 1 indicate the following compounds.
- the values in Table 1 are parts by weight.
- YD128 Bisphenol A type epoxy resin (Toto Kasei Co., Ltd.)
- OPP-G orthophenylphenol glycidyl ether (Sanko Co., Ltd.)
- UVR6110 3,4 Epoxycyclohexylmethyl-3,4 Epoxycyclohexane power 2-BPMOX: Compound synthesized above
- RSOX Compound represented by the following formula (12) (developed by Toagosei Co., Ltd.)
- HQOX a compound represented by the following formula (13) (developed by Toagosei Co., Ltd.)
- TMPOX Compound represented by the following formula (14) (Developed by Toagosei Co., Ltd.)
- A200 Athalylate having alicyclic epoxy group (Cyclomer A200, manufactured by Daicel Chemical Industries, Ltd.)
- UVI-6992 Triaryl sulfo-dimethylhexafluorophosphate (Dow Chemical Nippon Co., Ltd., photo-induced thione polymerization initiator)
- Example 3 Transparency was evaluated for each of the compositions of Example 7 and Comparative Example 1 which were cured by irradiation with ultraviolet rays. That is, a double-sided tape was attached to one side of a 1-mm-thick slide glass to form a spacer, and the composition was placed between the two pieces of glass.
- the UV irradiation conditions were a 60 WZcm high-pressure mercury lamp, a lamp height of 30 cm (150 mWZcm 2 ), an irradiation time of 20 seconds, and irradiation from only one side.
- the UV-visible absorption spectrum of the used slide glass is shown in Fig. 1 for reference.
- the thickness of the cured resin portion was about 0.25 mm.
- the visible absorption spectrum of the cured product was measured without sandwiching a substrate or the like on the reference light side in a state of being sandwiched between two slide glasses.
- the measurement results are shown in Figure 2 (transmittance spectrum from 380 to 700 nm) and Table 3 (transmittance at 400 nm and 380 nm).
- the transmittance around 400 nm is clearly higher and the yellowing is smaller than that of the comparative example 1.
- Example 3 and Comparative Example 2 Transparency was evaluated for each of the compositions of Comparative Example 5 which were cured by irradiation with ultraviolet rays. That is, a lmm-thick PMMA substrate is enclosed on one side with double-sided tape to form a spacer, the composition is placed in it, and a 50 ⁇ m-thick layer from the top is used to smooth the cured surface.
- a PET film (Lumirror 50-T60, manufactured by Toray Industries, Inc.) was laminated, irradiated with ultraviolet light, and cured.
- the UV irradiation conditions were a 60 WZcm high-pressure mercury lamp, a lamp height of 30 cm (150 mWZcm 2 ), and an irradiation time of 30 seconds.
- Irradiation was performed only from the PET side.
- the UV-visible absorption spectrum of the PET film used is shown in FIG. Then, in order to see yellowing when directly irradiating light with a light source power, Removed and irradiated for 15 seconds.
- the thickness of the resin portion after curing was about 0.25 mm.
- Example 3 Each of the compositions of Example 5, Comparative Example 2 and Comparative Example 3 was evaluated for curability and adhesion.
- Example 3 Comparing the refractive indices of Example 3 and Comparative Example 3, Example 3 is higher. This indicates that it is better to use a compound having one oxetanyl group than a compound having two oxetanyl groups. Further, as shown in Examples 3 and 4, it is shown that a coating film having good adhesion and transparency can be obtained and the refractive index can be controlled.
- the cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays, touch panels, and optical lenses. It can be suitably used as a required optical material.
- the cured product obtained from the composition containing the compound represented by the formula (4) of the present invention has a high refractive index, and is excellent in curability, heat resistance, flame retardancy, and mechanical properties. It can be used for paints, coating materials, adhesives and the like.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Polyethers (AREA)
- Polymerisation Methods In General (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020067020105A KR101111372B1 (en) | 2004-03-04 | 2005-03-01 | Ultraviolet-curing composition |
JP2006510668A JP4548415B2 (en) | 2004-03-04 | 2005-03-01 | UV curable composition |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-060195 | 2004-03-04 | ||
JP2004060195 | 2004-03-04 | ||
JP2004060137 | 2004-03-04 | ||
JP2004-060137 | 2004-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005085317A1 true WO2005085317A1 (en) | 2005-09-15 |
Family
ID=34921672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/003351 WO2005085317A1 (en) | 2004-03-04 | 2005-03-01 | Ultraviolet-curing composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP4548415B2 (en) |
KR (1) | KR101111372B1 (en) |
TW (1) | TWI366576B (en) |
WO (1) | WO2005085317A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005336349A (en) * | 2004-05-27 | 2005-12-08 | Toagosei Co Ltd | Cationically polymerizable composition |
JP2007169567A (en) * | 2005-12-26 | 2007-07-05 | Nitto Denko Corp | Optical sheet, substrate for image display device, liquid crystal display device, organic el display device and solar battery |
JP2008184563A (en) * | 2007-01-31 | 2008-08-14 | Nikon Corp | Resin composition for high aspect ratio structure |
WO2010116929A1 (en) * | 2009-04-06 | 2010-10-14 | ダイセル化学工業株式会社 | Cation-polymerizable resin composition and cured product thereof |
JP2012017471A (en) * | 2011-09-29 | 2012-01-26 | Nitto Denko Corp | Optical sheet, substrate for image display device, liquid crystal display device, organic el display device and solar cell |
WO2012173054A1 (en) * | 2011-06-11 | 2012-12-20 | 東亞合成株式会社 | Active-energy-ray-curable adhesive composition for plastic film or sheet |
JP2013023574A (en) * | 2011-07-21 | 2013-02-04 | Jsr Corp | Radiation-curable liquid resin composition for optical stereolithography, and optically shaped article obtained by photocuring the same |
JPWO2012020688A1 (en) * | 2010-08-12 | 2013-10-28 | 株式会社ダイセル | Low moisture-permeable resin composition and cured product thereof |
WO2015151782A1 (en) * | 2014-03-31 | 2015-10-08 | 日東電工株式会社 | Resin composition for use in optical component and optical component using same |
WO2015151688A1 (en) * | 2014-03-31 | 2015-10-08 | 日東電工株式会社 | Resin composition for use in optical component and optical component using same |
CN105384913A (en) * | 2015-12-04 | 2016-03-09 | 南昌大学 | Purely cationic photosensitive resin for 3D printing stereolithographic rapid prototyping, and preparation method and application thereof |
WO2017221935A1 (en) * | 2016-06-21 | 2017-12-28 | 株式会社Adeka | Curable composition, method for producing cured product, and cured product of same |
KR20190130045A (en) * | 2017-07-28 | 2019-11-20 | 주식회사 다이셀 | Monomer Mixture and Curable Composition Comprising the Same |
JP2020200461A (en) * | 2019-06-10 | 2020-12-17 | パナソニックIpマネジメント株式会社 | Ultraviolet curable resin composition, method for producing light emitting device and light emitting device |
WO2023132249A1 (en) * | 2022-01-04 | 2023-07-13 | 三井化学株式会社 | Resin composition for lens, cured product for lens, and lens |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102248518B1 (en) | 2017-12-27 | 2021-05-04 | 주식회사 엘지화학 | Photopolymerizable composition for forming bezel pattern, method of manufacturing bezel pattern using the same, and bezel pattern prepared by using the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60184071A (en) * | 1984-02-29 | 1985-09-19 | Dai Ichi Kogyo Seiyaku Co Ltd | Glycidyl ether compound of hexabromo-p-phenylphenol |
JPH0497887A (en) * | 1990-08-16 | 1992-03-30 | Oji Paper Co Ltd | Thermal recording material |
JP2002194056A (en) * | 2000-12-27 | 2002-07-10 | Nippon Kayaku Co Ltd | Epoxy resin composition and its cured product |
JP2003138006A (en) * | 2001-10-31 | 2003-05-14 | Toagosei Co Ltd | Energy ray-curable composition |
JP2003313271A (en) * | 2002-04-19 | 2003-11-06 | Toagosei Co Ltd | Active energy ray-curable resin composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3508502B2 (en) * | 1997-09-30 | 2004-03-22 | 宇部興産株式会社 | Biphenyl derivative having oxetane ring |
JP4380043B2 (en) * | 2000-09-06 | 2009-12-09 | 東亞合成株式会社 | Methylene bisphenol derivative mixture having oxetane ring |
JP2003335765A (en) * | 2002-05-20 | 2003-11-28 | Nippon Kayaku Co Ltd | Fluorine atom-containing polyfunctional oxetane compound, resin composition using the same, coating agent for optical fiber and cured product |
-
2005
- 2005-03-01 WO PCT/JP2005/003351 patent/WO2005085317A1/en active Application Filing
- 2005-03-01 KR KR1020067020105A patent/KR101111372B1/en not_active IP Right Cessation
- 2005-03-01 JP JP2006510668A patent/JP4548415B2/en active Active
- 2005-03-03 TW TW094106421A patent/TWI366576B/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60184071A (en) * | 1984-02-29 | 1985-09-19 | Dai Ichi Kogyo Seiyaku Co Ltd | Glycidyl ether compound of hexabromo-p-phenylphenol |
JPH0497887A (en) * | 1990-08-16 | 1992-03-30 | Oji Paper Co Ltd | Thermal recording material |
JP2002194056A (en) * | 2000-12-27 | 2002-07-10 | Nippon Kayaku Co Ltd | Epoxy resin composition and its cured product |
JP2003138006A (en) * | 2001-10-31 | 2003-05-14 | Toagosei Co Ltd | Energy ray-curable composition |
JP2003313271A (en) * | 2002-04-19 | 2003-11-06 | Toagosei Co Ltd | Active energy ray-curable resin composition |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005336349A (en) * | 2004-05-27 | 2005-12-08 | Toagosei Co Ltd | Cationically polymerizable composition |
JP2007169567A (en) * | 2005-12-26 | 2007-07-05 | Nitto Denko Corp | Optical sheet, substrate for image display device, liquid crystal display device, organic el display device and solar battery |
JP2008184563A (en) * | 2007-01-31 | 2008-08-14 | Nikon Corp | Resin composition for high aspect ratio structure |
WO2010116929A1 (en) * | 2009-04-06 | 2010-10-14 | ダイセル化学工業株式会社 | Cation-polymerizable resin composition and cured product thereof |
JP2010241959A (en) * | 2009-04-06 | 2010-10-28 | Daicel Chem Ind Ltd | Cationically polymerizable resin composition and cured product thereof |
JPWO2012020688A1 (en) * | 2010-08-12 | 2013-10-28 | 株式会社ダイセル | Low moisture-permeable resin composition and cured product thereof |
JP5812993B2 (en) * | 2010-08-12 | 2015-11-17 | 株式会社ダイセル | Low moisture-permeable resin composition and cured product thereof |
WO2012173054A1 (en) * | 2011-06-11 | 2012-12-20 | 東亞合成株式会社 | Active-energy-ray-curable adhesive composition for plastic film or sheet |
JP2013023574A (en) * | 2011-07-21 | 2013-02-04 | Jsr Corp | Radiation-curable liquid resin composition for optical stereolithography, and optically shaped article obtained by photocuring the same |
JP2012017471A (en) * | 2011-09-29 | 2012-01-26 | Nitto Denko Corp | Optical sheet, substrate for image display device, liquid crystal display device, organic el display device and solar cell |
JP2015194546A (en) * | 2014-03-31 | 2015-11-05 | 日東電工株式会社 | Optical component resin composition and optical components produced using the same |
JP2015194547A (en) * | 2014-03-31 | 2015-11-05 | 日東電工株式会社 | Optical component resin composition and optical components produced using the same |
WO2015151688A1 (en) * | 2014-03-31 | 2015-10-08 | 日東電工株式会社 | Resin composition for use in optical component and optical component using same |
WO2015151782A1 (en) * | 2014-03-31 | 2015-10-08 | 日東電工株式会社 | Resin composition for use in optical component and optical component using same |
CN105934690A (en) * | 2014-03-31 | 2016-09-07 | 日东电工株式会社 | Resin composition for use in optical component and optical component using same |
CN105384913A (en) * | 2015-12-04 | 2016-03-09 | 南昌大学 | Purely cationic photosensitive resin for 3D printing stereolithographic rapid prototyping, and preparation method and application thereof |
JPWO2017221935A1 (en) * | 2016-06-21 | 2019-04-11 | 株式会社Adeka | Curable composition, method for producing cured product, and cured product thereof |
WO2017221935A1 (en) * | 2016-06-21 | 2017-12-28 | 株式会社Adeka | Curable composition, method for producing cured product, and cured product of same |
JP7071262B2 (en) | 2016-06-21 | 2022-05-18 | 株式会社Adeka | Curable composition, method for producing cured product, and cured product thereof |
KR20190130045A (en) * | 2017-07-28 | 2019-11-20 | 주식회사 다이셀 | Monomer Mixture and Curable Composition Comprising the Same |
KR102084463B1 (en) | 2017-07-28 | 2020-03-04 | 주식회사 다이셀 | Monomer Mixture and Curable Composition Comprising the Same |
JP2020200461A (en) * | 2019-06-10 | 2020-12-17 | パナソニックIpマネジメント株式会社 | Ultraviolet curable resin composition, method for producing light emitting device and light emitting device |
JP7554992B2 (en) | 2019-06-10 | 2024-09-24 | パナソニックIpマネジメント株式会社 | Ultraviolet-curable resin composition, method for manufacturing light-emitting device, and light-emitting device |
WO2023132249A1 (en) * | 2022-01-04 | 2023-07-13 | 三井化学株式会社 | Resin composition for lens, cured product for lens, and lens |
Also Published As
Publication number | Publication date |
---|---|
JPWO2005085317A1 (en) | 2008-01-17 |
TW200609262A (en) | 2006-03-16 |
JP4548415B2 (en) | 2010-09-22 |
TWI366576B (en) | 2012-06-21 |
KR101111372B1 (en) | 2012-03-13 |
KR20070012386A (en) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005085317A1 (en) | Ultraviolet-curing composition | |
WO2012002028A1 (en) | Curable resin composition | |
WO2008029893A1 (en) | Liquid crystal sealing agent, method for manufacturing liquid crystal display panel using the liquid crystal sealing agent, and liquid crystal display panel | |
TW200940604A (en) | Organosilicon compounds which have oxetanyl groups, and a method for the production and curable compositions of the same | |
WO2017159637A1 (en) | Epoxy compound, curable composition, cured product, method for producing epoxy compound, and reactive diluent | |
TW201802176A (en) | Epoxy compound, curable composition containing this, and cured product of curable composition | |
JP2005336349A (en) | Cationically polymerizable composition | |
US20230331688A1 (en) | Diepoxy compound, curable composition, cured product, and optical member | |
CN100462385C (en) | Ultraviolet-curing composition | |
JP6691855B2 (en) | Curable composition and cured product obtained by curing the same | |
JP4251138B2 (en) | Curing accelerator for cationic polymerization type composition | |
JP2012177038A (en) | Epoxy resin composition | |
US7612123B2 (en) | Cyclohexene oxide compound having cyclohexyl group or long-chain alkyl group, and use thereof | |
JP4873203B2 (en) | Method of curing curable oxetane composition | |
JP5642930B2 (en) | Liquid curable composition and cured product thereof | |
JP2008297271A (en) | Oxetane compound and curable composition | |
JP4760827B2 (en) | 1,3-propanediol derivative having oxetane ring | |
WO2017213205A1 (en) | Epoxy compound, curable composition containing this, and cured product of curable composition | |
JP4352862B2 (en) | Cycloaliphatic compounds having an oxetane ring | |
JP4910871B2 (en) | Epoxy resin composition and transparent composite sheet | |
JP2019189789A (en) | Adhesive composition for thin film, laminate using the same, and manufacturing method of laminate | |
WO2023145580A1 (en) | Diepoxy compound, curable composition, cured product, and optical member | |
JP2005336333A (en) | Actinic radiation curing composition | |
TW201630878A (en) | Sulfonium borate salt, acid generating agent and curable composition | |
JP2002265560A (en) | Novel epoxy compound and active energy ray-curable epoxy resin composition therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 200580006680.7 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067020105 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067020105 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006510668 Country of ref document: JP |